Bio-Rad Laboratories | BIO - 债务





债务 更改 日
Abbott USD 34.05B 20.19B 2026-03
Agilent USD 3.36B 1000K 2026-03
Becton, Dickinson and Co. USD 17.28B 2.26B 2026-03
Bio Techne USD 200M 0 2026-06
Bio-Rad Laboratories USD 1.37B 7.8M 2026-06
Bruker USD 1.82B 153.5M 2026-06
Charles River Laboratories USD 3.06B 485.84M 2026-03
Danaher USD 26.56B 8.07B 2026-06
General Electric Aerospace USD 19.16B 1.12B 2026-06
Illumina USD 2.54B 9M 2026-03
IQVIA Holdings USD 16.24B 408M 2026-06
Laboratory Of America USD 7.24B 714.6M 2026-03
Merck USD 49.12B 222M 2026-03
Mettler Toledo International USD 2.23B 76.47M 2026-03
Myriad Genetics USD 59.3M 19.7M 2025-03
OraSure Technologies USD 782K 465K 2024-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Quest Diagnostics USD 6.41B 179M 2026-03
Repligen USD 690.94M 144.36M 2026-06
Revvity USD 3.35B 48.03M 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Siemens EUR 54.16B 2.3B 2026-03
Standard Biotools USD 29.49M 2.1M 2026-03
Thermo Fisher Scientific USD 43.16B 3.78B 2026-03
Tosoh JPY 228.91B 56.6B 2026-03
Waters USD 5.57B 4.08B 2026-03